Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Knockdown of PTEN in normal mammary epithelial cells implanted into humanized mouse fat pads resulted in disorganized, hyperplastic lesions (44).”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
In the citing paper
“These outgrowths displayed increased basal markers (smooth muscle actin, CK5, CK6) and decreased luminal markers (estrogen receptor, CK18), similar to our findings with mislocalization of SCRIB.”
From Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer (2014) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012 · cited 8×
“Mammary tissue from reduction mammoplasties was dissociated as previously described [19].”
BackgroundMethodInfluentialSelf-citationA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188 · cited 1×
“screened 38 breast cancer cell lines including MCF7 for various pathways and found that MCF7 cells displayed significantly low levels of the PI3/Akt activation when compared with other cell lines [52].”
BackgroundmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561 · cited 1×
“loop [43–46].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406 · cited 2×
“Mammosphere cultures were grown in a serum-free mammary epithelium basal medium as previously described [18].”
BackgroundMethodSelf-citationSato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,109 · cited 1×
“To examine the role of Wnt/b-catenin signaling, we used the GSK3-b inhibitor 6-bromoindirubin-39-oxime (Bio), which has been shown to be able to maintain pluripotency of human and mouse embryonic stem cells through activation of bcatenin signaling [30].”
MethodNagata, Y., Lan, K.-H., Zhou, X., Tan, M., Esteva, F. J., Sahin, A. A., Klos, K. S., Li, P., Monia, B. P., Nguyen, N. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.022 · Cited by 1,858 · cited 2×
“therapeutic agents and relapse following initial treatment [7,8].”
BackgroundInfluentialIntrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794 · cited 1×
“Recent evidence utilizing in vitro systems [56], animal models [13], and clinical trials have suggested that breast cancer stem cells are relatively resistant to both radiation and chemotherapy [57].”
BackgroundBerns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Purification and unique properties of mammary epithelial stem cells
Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H. I., & Eaves, C. J. (2006) · Nature · doi:10.1038/nature04496 · Cited by 1,559 · cited 1×
“Furthermore, recent studies have shown that mammary stem cells are not contained within the SP population [47].”
BackgroundPten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516 · cited 2×
“heterozygous mice developing tumors in several organs including the breast [5,34].”
Background
Cited by
Items 201–300 of 532
Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells
Zhou, W., Wang, G., & Guo, S. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.003 · Cited by 64
“Several oncogenes, such as HER2 [105,106], Akt [107] as well as transcriptional factors, such as STAT3 [108], NFκB [109] were recently found to be associated with BCSC.”
BackgroundOsaki, M., Okada, F., & Ochiya, T. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.122 · Cited by 56
Flamme, M., Cressey, P., Lü, C., Bruno, P. M., Eskandari, A., Hemann, M. T., Hogarth, G., & Suntharalingam, K. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701837 · Cited by 54
Bhutia, S. K., Das, S. K., Azab, B., Menezes, M. E., Dent, P., Wang, X., Sarkar, D., & Fisher, P. B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28289 · Cited by 52
“Similarly, Akt (protein kinase B) is a central regulator in the Wnt and PI3K signaling pathways.(10) Apoptosis resistance, a characteristic feature of cancer cells, has been demonstrated prominently in cancer-initiating/stem cells.”
BackgroundAkt-mediated phosphorylation of Oct4 is associated with the proliferation of stem-like cancer cells
Zhao, Q. D., ZHOU, Y.-W., Li, W., Kang, B., Zhang, X., Yang, Y., Cheng, J., Yin, S., Tong, Y., He, J., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3752 · Cited by 52
“The effects of Akt were thought to be mediated by the activation of the Wnt/β-catenin pathway and GSK3β phosphorylation in mammary stem/progenitor cells (41), and by Akt-induced ABCG2 activation in glioblastoma stem-like cells (42).”
BackgroundIdentifying and targeting tumor-initiating cells in the treatment of breast cancer
Wei, W., & Lewis, M. T. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0447 · Cited by 62
“Although anti-HER2 agents have been shown to target breast TICs with, or sometimes without, HER2 amplification (Korkaya et al. 2009, Magnifico et al. 2009, Ithimakin et al. 2013), several lines of evidence support http://erc.endocrinology-journals.org q 2015 Society for Endocrinology DOI:…”
BackgroundShao, K., Shi, T., Yang, Y., Wang, X., Xu, D., & Zhou, P. (2016) · Tumor Biology · doi:10.1007/s13277-016-5440-0 · Cited by 52
“Considering that Wnt/β-catenin signaling regulates the expression of CCND1 and obtains a crosstalk with PI3K/AKT signaling [24, 25], we further found that silencing CRNDE inhibits the activation of Wnt/β-catenin signaling in 786-O and A498 cell lines.”
BackgroundThomas, C., Henry, W. S., Cuiffo, B., Collmann, A. Y., Marangoni, E., Benhamo, V., Bhasin, M., Fan, C., Fuhrmann, L., Baldwin, A. S., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah4674 · Cited by 57
Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population
Luk, S.-U., Lee, T. K., Liu, J., Lee, D. T., Chiu, Y., Ma, S., Ng, I. O., Wong, Y. C., Chan, F. L., & Ling, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019804 · Cited by 57
“Aberrant activation of the Akt/b-catenin pathway through the knockdown of Pten was found to enrich the mammary stem cell population, leading to the induction of hyperplastic lesions in the mouse [30].”
BackgroundGranulin-Epithelin Precursor Is an Oncofetal Protein Defining Hepatic Cancer Stem Cells
Cheung, P. F. Y., Cheng, C. K. C., Wong, N. C. L., Ho, J. C.-Y., Yip, C. W., Lui, V. C. H., Cheung, A., Fan, S. T., & Cheung, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028246 · Cited by 51
“PI3K/Akt plays crucial role in proliferation, survival, and maintenance of pluripotency in ES cells [30,31], and these effects were found to mediate through the phosphorylation of GSK3b, leading to increased Wnt/b-catenin activity [32,33].”
BackgroundAptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Shamaileh, H. A., Wang, T., Xiang, D., Yin, W., Tran, P. H. L., Barrero, R. A., Zhang, P., Li, Y., Kong, L., Liu, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05859-z · Cited by 52
Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation
Nathansen, J., Meyer, F., Müller, L., Schmitz, M., Borgmann, K., & Dubrovska, A. (2021) · Cancers · doi:10.3390/cancers13194818 · Cited by 54
Daverey, A., Drain, A. P., & Kidambi, S. (2015) · Scientific Reports · doi:10.1038/srep13744 · Cited by 51
Regulation of colon cancer recurrence and development of therapeutic strategies
Kanwar, S. S. (2012) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v3.i1.1 · Cited by 50
Lee, J. H., Shu, L., Fuentes, F., Su, Z., & Kong, A. T. (2013) · Journal of Traditional and Complementary Medicine · doi:10.4103/2225-4110.107700 · Cited by 52
“The CSC model asserts that a small distinct population of tumorigenic cells that is capable of self-renewal and perpetual proliferation initiates and develops cancer.[122,123] Tumors following the CSC model contain intrinsically different subpopulations of tumorigenic and nontumorigenic cells organized in a hierarchy.”
BackgroundEskandari, A., Boodram, J. N., Cressey, P., Lü, C., Bruno, P. M., Hemann, M. T., & Suntharalingam, K. (2016) · Dalton Transactions · doi:10.1039/c6dt03811e · Cited by 50
Liu, X., Xiong, H., Huang, J., Qi, K., & Xu, J. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12780 · Cited by 50
Ramirez, C. N., Li, W., Zhang, C., Wu, R., Su, S., Wang, C., Gao, L., Yin, R., & Kong, A. T. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0177-2 · Cited by 55
Schaefer, T., Steiner, R., & Lengerke, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144902 · Cited by 55
“A first indicator of such connectivity was the PI3K/AKT cross-reactive inhibitor perifosine, which attenuated PTEN-mutant induced outgrowth of human mammary epithelium-derived stem cells [66].”
BackgroundYin, L., Zhang, X., Bian, X., Guo, Y.-M., & Wang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107369 · Cited by 50
“Many signaling pathways involved in regulation of normal mammary stem cells including Hedgehog, Bmi-1, Wnt, NOTCH, HER2, p53 and PTEN/Akt/b-catenin pathways play roles in breast cancer stem/ progenitor cells [46–49].”
BackgroundMandal, S., Gamit, N., Varier, L., Dharmarajan, A., & Warrier, S. R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118854 · Cited by 51
Banerjee, A., Qian, P., Wu, Z., Ren, X., Steiner, M., Bougen-Zhukov, N. M., Liu, S., Liu, D., Zhu, T., & Lobie, P. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365163 · Cited by 52
“To confirm that the increased mammospheric growth represented the progeny of individual cells rather than the aggregation of quiescent cells, we performed self-renewal assays (32).”
MethodRiggio, M., Polo, M. L., Blaustein, M., Colman‐Lerner, A., Lüthy, I. A., Lanari, C., & Novaro, V. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr303 · Cited by 54
de Aberasturi, A. L., Redrado, M., Villalba-Esparza, M., Larzábal, L., Pajares, M. J., Garcia, J., Evans, S. R., García-Ros, D., Bodegas, M. E., López, L., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.012 · Cited by 49
Sun, L., Burnett, J., Gasparyan, M., Xu, F., Jiang, H., Lin, C.-C. A., Myers, I., Körkaya, H., Liu, Y., Connarn, J. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9839 · Cited by 54
“Long term treatment with trastuzumab was carried out for greater than 3 months as previous described [10, 49], and were otherwise maintained in the same media as the parental cell line.”
BackgroundSelf-citationOncogenic miRNAs and target therapies in colorectal cancer
Saberinia, A., Alinezhad, A., Jafari, F., Soltany, S., & Akhavan‐Sigari, R. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.012 · Cited by 50
Ables, E. T., Laws, K. M., & Drummond‐Barbosa, D. (2012) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.48 · Cited by 51
Tseng, C., Hong, Y., Chang, H., Yu, T.-J., Hung, T.-W., Hou, M., Yuan, S. F., Cho, C.-L., Liu, C.-T., Chiu, C., et al. (2014) · Molecules · doi:10.3390/molecules191117464 · Cited by 49
The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer
Xu, W., Lacerda, L., Debeb, B. G., Atkinson, R. L., Solley, T. N., Li, L., Orton, D., McMurray, J. S., Hang, B. I., Lee, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071508 · Cited by 47
“Drugs that have been reported to inhibit TICs include salinomycin, an anticoccidiostat ionophore [29]; repertaxin, a small molecule inhibitor of CXCR1 [30]; sulforaphane, a dietary component of broccoli and broccoli sprouts that inhibits WNT signaling [31]; and perifosine, a small molecule inhibitor of AKT signaling […”
BackgroundRole of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal
Rivas-Muñoz, S., Gómez-Oro, C., Antón, I. M., & Wandosell, F. G. (2018) · Biomedicines · doi:10.3390/biomedicines6010029 · Cited by 51
“Furthermore, some authors have described that β-catenin is essential to promote tumorigenic capacity downstream of Akt [24,42,82], as it is a partner of the YAP/TAZ proteins [83].”
BackgroundWang, C., Peng, R., Zeng, M., Zhang, Z., Liu, S., Jiang, D., Lu, Y., & Zou, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03265-4 · Cited by 49
Cancer stem cells: nature versus nurture
Körkaya, H., & Wicha, M. S. (2010) · Nature Cell Biology · doi:10.1038/ncb0510-419 · Cited by 47
Self-citationMarić, G., Annis, M. G., MacDonald, P. A., Russo, C., Perkins, D., Siwak, D. R., Mills, G. B., & Siegel, P. M. (2019) · Oncogene · doi:10.1038/s41388-019-0793-7 · Cited by 53
Limitations of therapies exposed
Casanovas, O. (2012) · Nature · doi:10.1038/484044a · Cited by 49
D’Uva, G., Bertoni, S., Lauriola, M., Carolis, S. D., Pacilli, A., D'Anello, L., Santini, D., Taffurelli, M., Ceccarelli, C., Yarden, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080742 · Cited by 48
“Beta-catenin is a crucial regulator of normal and cancer stem cell self-renewal [6,7].”
BackgroundOct4 Interaction with Hmgb2 Regulates Akt Signaling and Pluripotency
Campbell, P. A., & Rudnicki, M. A. (2013) · Stem Cells · doi:10.1002/stem.1365 · Cited by 46
Ding, S., & Zheng, P. (2012) · Gut Pathogens · doi:10.1186/1757-4749-4-18 · Cited by 50
“These inflammatory mediators and oncogenic pathways also regulate stem cell differentiation either directly or indirectly and are frequently deregulated in tumors [54-56].”
Backgroundde la Mare, J., Sterrenberg, J. N., Sukhthankar, M., Chiwakata, M. T., Beukes, D. R., Blatch, G. L., & Edkins, A. L. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-39 · Cited by 49
“only a specific subset of the bulk MCF-7 population, displaying unique functional and phenotypic characteristics, was capable of propagation in suspension and validated the mammosphere assay employed [7,19].”
MethodInvestigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem Cells
Tomao, F., Papa, A., Strudel, M., Rossi, L., Russo, G. L., Panici, P. B., Ciabatta, F. R., & Tomao, F. (2014) · Journal of Cancer · doi:10.7150/jca.8610 · Cited by 51
“Other pathways involved in carcinogenesis, such as Hedgehog and Wnt, originate from the microenvironment of the SC niche [25,26].”
BackgroundThioridazine has potent antitumor effects on lung cancer stem-like cells
Shen, J., Ma, B., Zhang, X., Sun, X., Han, J., Wang, Y., Chu, L., Xu, H., & Yu, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.5651 · Cited by 45
Song, R., Fullerton, D. A., Ao, L., Zhao, K., Reece, T. B., Cleveland, J. C., & Meng, X. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005364 · Cited by 48
“The phosphoinositide phosphatase PTEN converts PIP3 to PIP2 and thereby negatively modulates AKT activity,(31) thus downregulation of PTEN can upregulate AKT phosphorylation.(43,53)”
BackgroundQi, Y., Liu, J., Chao, J. C., Scheuerman, M. P., Rahimi, S. A., Lee, L. Y., & Li, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-69698-1 · Cited by 50
Gao, Q., Guo, M., Jiang, X., Hu, X., Wang, Y., & Fan, Y. (2014) · Stem Cells International · doi:10.1155/2014/162024 · Cited by 45
Stem-Like Cells and Therapy Resistance in Squamous Cell Carcinomas
Facompre, N. D., Nakagawa, H., Herlyn, M., & Basu, D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-397927-8.00008-7 · Cited by 45
“Notch pathways play key regulatory roles in adult stem cells in various tissues (Blanpain et al., 2006; Brabletz et al., 2009; Conboy & Rando, 2001; Fre et al., 2005; Korkaya et al., 2009).”
BackgroundNorcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
Hsieh, C.-H., Chao, K. S. C., Liao, H., & Chen, Y.-J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/838651 · Cited by 45
Marsden, C. G., Wright, M. J., Carrier, L., Moroz, K., Pochampally, R. R., & Rowan, B. G. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-10 · Cited by 48
The role of cancer stem cells in the anti‐carcinogenicity of curcumin
Norris, L., Karmokar, A., Howells, L. M., Steward, W. P., Gescher, A. J., & Brown, K. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300120 · Cited by 43
“Inhibition of canonical Wnt signalling through -catenin lentiviral shRNA knockdown, reduced mamosphere formation by 70% and suggests that mammary stem cell self-renewal are mediated through -catenin signalling [11].”
BackgroundEmerging role of microRNAs in cancer stem cells: Implications in cancer therapy
Garg, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i8.1078 · Cited by 43
Wnt Signaling in the Breast: From Development to Disease
de Oliveira, W. A. A., Laithy, Y. E., Bruna, A., Annibali, D., & Lluís, F. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.884467 · Cited by 46
“Following the explosion of scientific interest in stem cell biology, a large number of studies were conducted to identify and characterize in detail the murine mammary gland stem cells and hierarchical differentiation (Stingl et al., 2006; Ginestier et al., 2007; Korkaya et al., 2009; Inman et al., 2015).”
BackgroundTakehara, M., Hoshino, T., Namba, T., Yamakawa, N., & Mizushima, T. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.02.012 · Cited by 45
“It has also been recently reported that the Wnt/b-catenin canonical signaling pathway plays an important role in the maintenance of self-renewal and pluripotency activities in not only mammary gland stem cells but also in brain and colon stem cells [25–27,52].”
BackgroundKamalıdehghan, B., Ahmadipour, F., Noordin, M. I., Mohan, S., Arya, A., Paydar, M., Looi, C. Y., Keong, Y. S., Nigjeh, S. E., Fani, S., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s72127 · Cited by 55
“Further, CSCs contribute to tumor resistance/relapse due to the inability of chemotherapy and radiation therapy to eradicate them.(22,35,36) Several bioactive dietary compounds, including curcumin,(37,38) quercetin, and epigallocatechin gallate,(39) have been reported to potentially target the self-renewal pathways of…”
Alva, J. A., Lee, G. E., Escobar, E. E., & Pyle, A. D. (2011) · Stem Cells · doi:10.1002/stem.748 · Cited by 43
DNA repair: the culprit for tumor-initiating cell survival?
Mathews, L., Cabarcas‐Petroski, S., & Farrar, W. L. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9277-0 · Cited by 46
“HOX genes have recently been connected to the PcG proteins, such as EZH2 [ 64 ].”
BackgroundRepurposing metformin for the treatment of gastrointestinal cancer
Júnior, A. D. D. C., Bragagnoli, A. S. C., Costa, F. O., & Carvalheira, J. B. C. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i17.1883 · Cited by 46
LIU, Y., ZOU, T., WANG, S., Chen, H., Su, D., Fu, X., Zhang, Q., & Kang, X. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3351 · Cited by 46
Targeting IL-8 signalling to inhibit breast cancer stem cell activity
Singh, J. K., Simões, B. M., Clarke, R. B., & Bundred, N. J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.835398 · Cited by 47
“This was SRC-dependent and led to the activation of AKT and ERK1/2 signalling pathways which are known to be critical in regulating breast CSC activity [10,33].”
BackgroundCell Fusion Hypothesis of the Cancer Stem Cell
Lü, X., & Kang, Y. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_6 · Cited by 41
Molecular and functional interactions between AKT and SOX2 in breast carcinoma
Schaefer, T., Wang, H., Mir, P., Konantz, M., Pereboom, T. C., Paczulla, A., Merz, B., Fehm, T. N., Perner, S., Rothfuss, O. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6183 · Cited by 41
“Furthermore, the PI3K/AKT pathway has been implicated in healthy and malignant breast stem cell biology [20].”
BackgroundXie, W., Zhang, Y., Zhang, S., Wang, F., Zhang, K., Huang, Y., Zhou, Z., Huang, G., & Wang, J. (2019) · PubMed · Cited by 54
Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation
Qin, X., Zhang, H., Zhang, P., Li, Y., Xu, M., Li, X., Li, X., & Dong, L. (2020) · Oncogene · doi:10.1038/s41388-020-01400-1 · Cited by 47
“Previous studies show loss of PTEN triggers development of CSCs, ultimately leading to tumorigenesis and recurrence [38].”
BackgroundQiu, Y., Yang, L., Liu, H., & Luo, X. (2021) · Stem Cells · doi:10.1002/stem.3381 · Cited by 44
“HER2 and PTEN are important in the regulation of BCSC properties.(44,45) Burnett et al and other research groups revealed that loss of PTEN induced EMT, increased”
BackgroundNengroo, M. A., Verma, A., & Datta, D. B. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155916 · Cited by 42
Qin, J., Ji, J., Deng, R., Tang, J., Yang, F., Feng, G., Chen, W.-D., Wu, X.-Q., Qian, X.-J., Ding, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3128 · Cited by 39
“Activation of the PI3K/AKT pathways is critical for the regulation and maintenance of cancer stem-like cells in breast cancer, prostate cancer, esophageal cancer, glioblastoma multiforme, and non-small cell lung cancer [4, 14, 15, 36, 38, 39].”
BackgroundMatrix compliance and RhoA direct the differentiation of mammary progenitor cells
Lui, C., Lee, K., & Nelson, C. M. (2011) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-011-0362-7 · Cited by 40
Distinct Effects of EGFR Ligands on Human Mammary Epithelial Cell Differentiation
Mukhopadhyay, C., Zhao, X., Maroni, D. M., Band, V., & Naramura, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075907 · Cited by 41
“However, activation of the PI3K-Akt pathway is also associated with the expansion of the mammary stem/progenitor populations and inhibition of differentiation [43].”
BackgroundEZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells
Mu, Z., Li, H., Fernandez, S. V., Alpaugh, K. R., Zhang, R., & Cristofanilli, M. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-70 · Cited by 38
“The CSC population is also thought to play a key role in breast cancer development, progression, and relapse following treatments [23-27].”
BackgroundInfluentialXu, W., Debeb, B. G., Lacerda, L., Li, J., & Woodward, W. A. (2011) · Cancers · doi:10.3390/cancers3022274 · Cited by 43
“Recently, it was reported tetrandrine inhibited β-catenin signaling in a colon cancer xenograft model [12],which is of interest given that β-catenin plays an important role in breast cancer TICs [13,14].”
BackgroundPatel, N. J., Sharon, C., Baranwal, S., Boothello, R. S., Desai, U. R., & Patel, B. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12358 · Cited by 38
“The TCF4 signaling pathway is known to be a major regulator of CSC phenotype in colon and breast cancer and could be one of the mechanisms involved in HS06 action [41, 42].”
BackgroundB591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells
Zhou, H., Yu, C., Kong, L., Xu, X., Yan, J., Li, Y., An, T., Gong, L., Gong, Y., Zhu, H., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0674-5 · Cited by 39
Li, Y., Yan, X., Shi, J., He, Y., Xu, J., Lin, L., Chen, W., Lin, X., & Lin, X. (2019) · BMC Cancer · doi:10.1186/s12885-019-5731-0 · Cited by 38
Gasparyan, M., Lo, M., Jiang, H., Lin, C.-C. A., & Sun, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010710 · Cited by 44
Nadal, R., Lorente, J. A., Rosell, R., & Serrano, M. J. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.7 · Cited by 37
Khodabandeh, Z., Valilo, M., Velaei, K., & Tazehkand, A. P. (2022) · Breast Cancer · doi:10.1007/s12282-022-01369-7 · Cited by 47
“CSC proliferation and maintenance are associated with the stimulation of anti-apoptotic pathways [112, 113], EMT [114], and confers chemoresistance phenotype [115], highlighting the importance of nicotine’s involvement in CSCs maintenance and proliferation through the activation of α7-nAChR receptor, which would be be…”
BackgroundTargeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
Nguyen, M. R., & Osipo, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126813 · Cited by 39
New promising drug targets in cancer- and metastasis-initiating cells
Mimeault, M., & Batra, S. K. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.009 · Cited by 45
Cai-McRae, X., Zhong, H., & Karantza, V. (2014) · Oncogene · doi:10.1038/onc.2014.244 · Cited by 38
Lustigman, S., Geldhof, P., Grant, W. N., Osei-Atweneboana, M. Y., Sripa, B., & Basáñez, M.-G. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001445 · Cited by 42
The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
Fonseca, N. A., Cruz, A. F., Moura, V., Simões, S., & Moreira, J. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.016 · Cited by 41
Fan, D., Lin, X., Zhang, F., Zhong, W., Hu, J., Chen, Y., Cai, Z., Zou, Y., He, X., Chen, X., et al. (2017) · Cancer Science · doi:10.1111/cas.13451 · Cited by 36
“Phosphatase and tensin homolog is a tumor suppressor gene that antagonizes PI3K/Akt signaling and is frequently silenced in numerous tumor types.(14,15) By inhibiting PI3K/Akt signaling, PTEN can inhibit bcatenin activity, ultimately affecting EMT.”
BackgroundInfluentialCancer stem cells: a systems biology view of their role in prognosis and therapy
Mertins, S. D. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000075 · Cited by 38
Li, Y., & Geng, Y. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.09.005 · Cited by 37
“The activation of GSK3β by phosphorylation leads to nuclear translocation of β-catenin [87], which can increase expression of Oct4 and Nanog during iPS cell formation.”
BackgroundLee, J. E., Lim, M. S., Park, J. H., Park, C., & Koh, H. C. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0200 · Cited by 35
The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20
Lee, E., Ouzounova, M., Piranlioglu, R., Thu, M., Güzel, M., Marasco, D., Chadli, A., Gestwicki, J. E., Cowell, J. K., Wicha, M. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0472-0 · Cited by 42
Self-citationGlycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane
Danker, K., Reutter, W. G., & Semini, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00626.x · Cited by 35
“…glioma and epithelial carcinoma cells) (Kondapaka et al., 2003; Ruiter et al., 2003; Dasmahapatra et al., 2004; Momota et al., 2005; Rahmani et al., 2005; Nyakern et al., 2006; Elrod et al., 2007; Engel et al., 2008; Na and Surh, 2008; Papa et al., 2008; Tazzari et al., 2008; Korkaya et al., 2009).”
BackgroundPandrangi, S. L., Chikati, R., Chauhan, P. S., Kumar, C. S., Banarji, A., & Saxena, S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1099-y · Cited by 35
Won, H. S., Lee, K. M., Oh, J. E., Nam, E. M., & Lee, K. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155983 · Cited by 35
Nanocarrier based approaches for targeting breast cancer stem cells
Pindiprolu, S. K. S. S., Krishnamurthy, P. T., Chintamaneni, P. K., & Karri, V. V. S. R. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1366337 · Cited by 38
PTEN Mediates Activation of Core Clock Protein BMAL1 and Accumulation of Epidermal Stem Cells
Zagni, C., Almeida, L. O., Balan, T., Martins, M. A. T., Rosselli‐Murai, L. K., Papagerakis, P., CASTILHO, R. M., & SQUARIZE, C. H. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.006 · Cited by 34
“In addition, reduced PTEN levels enrich normal and malignant human mammary SCs by activating the Wnt/b-catenin signaling pathway (Korkaya et al., 2009).”
BackgroundFarmakovskaya, M. D., Хромова, Н. В., Александровна, Р. В., Dugina, V. B., Kopnin, B. P., & Kopnin, P. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1156268 · Cited by 36
“lation of several genes (for example, TAZ, WNT, SHH, DKK1, PTEN, BMI-1) could influence the proportion of CSCs in cancer cell populations.(30-33) Taking into consideration that”
BackgroundHu, J., Lai, Y., Huang, H., Ramakrishnan, S., Pan, Y., Victor, W., Cheuk, W., So, G., He, Q., Lau, C. G., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01596-3 · Cited by 34
“We have also examined whether FZD8 or NOS2 is a mediator British Journal of Cancer (2022) 126:57 – 71 of TCOF1 in regulating CSCs. Overexpression of FZD8 or NOS2 did not rescue mammosphere formation impaired by TCOF1 knockout in TNBC cells (Fig.”
BackgroundInfluentialMartelli, A. M., Papa, V., Tazzari, P. L., Ricci, F., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Martinelli, G., Ottaviani, E., et al. (2010) · Leukemia · doi:10.1038/leu.2010.32 · Cited by 33
Cancer Stem Cells and Epithelial Ovarian Cancer
Dyall, S., Gayther, S. A., & Dafou, D. (2010) · Journal of Oncology · doi:10.1155/2010/105269 · Cited by 33
“The stem cell pool is also tightly regulated by signalling pathways from the microenvironment of the stem cell niche, and several of these pathways, including Hedgehog [7], and Wnt [8], have been implicated in carcinogenesis.”
BackgroundTargeting Cancer Stem Cells with Natural Products
Burnett, J., Newman, B. W., & Sun, D. (2012) · Current Drug Targets · doi:10.2174/138945012802009062 · Cited by 36
Lin, M., Chen, S., Tsai, H.-M., He, P., Lin, Y., Herschman, H. R., & Li, H. (2016) · Stem Cells · doi:10.1002/stem.2476 · Cited by 32
Mechanistic insights of adipocyte metabolism in regulating breast cancer progression
Zhang, F., & Liu, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104741 · Cited by 35
Zhang, G., Wang, W., Yao, C., Zhang, S., Liang, L., Han, M., Ren, J., Qi, X., Zhang, X., Wang, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20339 · Cited by 31
“Furthermore, AKT can directly phosphorylate β-catenin, an event which further facilitates its nuclear translocation [34].”
BackgroundSharon, C., Baranwal, S., Patel, N. J., Rodríguez‐Agudo, D., Pandak, W. M., Majumdar, A. P. N., Krystal, G. W., & Patel, B. B. (2015) · Oncotarget · doi:10.18632/oncotarget.3684 · Cited by 31
Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures
Morrison, B. J., Hastie, M. L., Grewal, Y. S., Bruce, Z. C., Schmidt, C., Reynolds, B. A., Gorman, J. J., & López, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052692 · Cited by 31
“phosphatase and tensin homolog – PTEN [12], EpCAM [13,14], mucin 1( MUC1) [15], CD44/CD24 populations [13,14], and aldehyde dehydrogenase 1 – ALDH1 [16,17] amongst others.”
PTEN-mediated resistance in cancer: From foundation to future therapies
Tufail, M. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101987 · Cited by 40
“Dysregulation of Wnt/ β -catenin signaling induced by PTEN loss may enhance cancer stem cell properties, fostering tumorigenesis and resistance to therapy [144], and PTEN deficiency may stimulate EMT through Wnt/ β -catenin signaling, promoting metastasis and resistance to therapeutics [147].”
Firat, E., & Niedermann, G. (2016) · Oncotarget · doi:10.18632/oncotarget.10702 · Cited by 33
Metadata
- Authors
- Korkaya, H., Paulson, A., Charafe-Jauffret, E., Ginestier, C., Brown, M., Dutcher, J., Clouthier, S. G., & Wicha, M. S.
- Affiliations
- University of Michigan (US)
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-02
- Volume
- 7
- Issue
- 6
- Pages
- e1000121
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC2683567
- OpenAlex
- W2009094422
- Cited by
- 523
- References
- 58
- Citations by year
- 2025: 8 · 2024: 11 · 2023: 16 · 2022: 21 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 23 · 2016: 39 · 2015: 59 · 2014: 42 · 2013: 65 · 2012: 64
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Michigan
- A. Alfred Taubman Medical Research Institute
- National Institutes of Health (CA46592)
- School of Medicine, Stanford University
- National Cancer Institute (CA101860, 5P30 CA 46592, R01CA129765, CA129765, R01CA101860, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- mammary stem/progenitor cells, PTEN, Akt signaling, Wnt/β-catenin signaling, breast cancer, perifosine, PI3K/Akt signaling, atypical hyperplasia, breast tumor xenografts, cancer stem cells
- MeSH terms
- Animals, Breast, Breast Neoplasms, Female, Gene Expression Regulation, Humans, Mammary Glands, Animal, Stem Cells, Neoplastic Stem Cells, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, PTEN Phosphohydrolase, beta Catenin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.